JTP 2942

Drug Profile

JTP 2942

Latest Information Update: 26 Mar 2007

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Japan Tobacco
  • Class Hormones; Nootropics; Small molecules
  • Mechanism of Action Thyrotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cerebral ischaemia; Cognition disorders

Most Recent Events

  • 31 Oct 2006 Discontinued - Phase-II for Cognition disorders in Japan (PO)
  • 31 Oct 2006 Discontinued - Preclinical for Cerebral ischaemia in Japan (PO)
  • 06 Mar 2001 A study has been added to the Neurological Disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top